文献

J-GLOBAL ID：201702215680606606   整理番号：17A1692820

TaqMan MTBおよびRCRapid M.TBと比べた中度結核出現率におけるXpert MTB/RIFの性能評価

Performance evaluation of Xpert MTB/RIF in a moderate tuberculosis incidence compared with TaqMan MTB and TRCRapid M.TB

著者 (8件)： Tsuyuguchi Kazunari (Clinical Research Center, Kinki-Chuo Chest Medical Center, National Hospital Organization, Japan) ,  Nagai Hideaki (Center for Pulmonary Diseases, Tokyo National Hospital, National Hospital Organization, Japan) ,  Ogawa Kenji (Department of Respiratory Medicine, Higashi Nagoya National Hospital, National Hospital Organization, Japan) ,  Matsumoto Tomoshige (Osaka Prefectural Medical Center for Respiratory and Allergic Diseases, Osaka Prefectural Hospital Organization, Japan) ,  Morimoto Kozo (Fukujuji Hospital, Japan Anti-Tuberculosis Association, Japan) ,  Takaki Akiko (Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Japan) ,  Mitarai Satoshi (Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Japan) ,  Mitarai Satoshi (Department of Basic Mycobacteriology, Graduate School of Biomedical Sciences, Nagasaki University, Japan)
資料名： Journal of Infection and Chemotherapy  (Journal of Infection and Chemotherapy)
巻： 23  号： 2  ページ： 101-106  発行年： 2017年02月 
JST資料番号： L2852A  ISSN： 1341-321X  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： イギリス (GBR)  言語： 英語 (EN)

抄録/ポイント： Xpert MTB/RIFは,臨床標本におけるMycobac...

シソーラス用語： ヒト ,...
準シソーラス用語： 核酸増幅検査

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1692820&from=J-GLOBAL&jstjournalNo=L2852A") }}

著者キーワード (3件)： Xpert MTB/RIF ,  MDR ,  TB

分類 (2件)： 感染症・寄生虫症の診断  (GD01020S) ,  微生物検査  (GC02030H)

引用文献 (40件)：

• World Health Organization. Global tuberculosis report 2015. Geneva, Switzerland. 2015. WHO/HTM/TB/2015.22.
• Kambashi B, Mbulo G, McNerney R, Tembwe R, Kambashi A, Tihon V, et al. Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis 2001;5:364-9.
• Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE. The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study. PLoS One 2012;7:e49898.
• World Health Organization. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF system. Geneva, Switzerland: WHO/HTM/TB/ 2011.4.
• Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. Xpert® MTB/ RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013;1:CD009593.

タイトルに関連する用語 (5件)： Tb ,  度 ,  結核 ,  出現率 ,  性能評価